Ionis Pharmaceuticals IONS Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's investing cash flow?
- Ionis Pharmaceuticals (IONS) reported investing cash flow of $536.82M in Q1 2026.
- How has Ionis Pharmaceuticals's investing cash flow changed year-over-year?
- Ionis Pharmaceuticals's investing cash flow increased by 214.9% year-over-year, from $170.46M to $536.82M.
- What is the long-term trend for Ionis Pharmaceuticals's investing cash flow?
- Over 2 years (2021 to 2025), Ionis Pharmaceuticals's investing cash flow has grown at a 19.4% compound annual growth rate (CAGR), from $194.91M to -$277.78M.
- What does investing cash flow mean?
- The net cash used for or generated by investment activities.
- How do you interpret investing cash flow?
- Negative values typically indicate growth-oriented investment in assets, while positive values often result from the liquidation of investments.
- How does investing cash flow compare across companies?
- Standard measure of investment activity across all industries.